PPA 904

Drug Profile

PPA 904

Alternative Names: PPA 904 PDT; PPA 904 photodynamic therapy

Latest Information Update: 23 Jun 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Photopharmica
  • Class Antibacterials; Oxidants; Phenothiazines
  • Mechanism of Action Photosensitisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Acne; Diabetic foot ulcer; Leg ulcer; Leishmaniasis; Wounds

Most Recent Events

  • 19 Jan 2009 Photopharmica initiates a phase II trial in patients with chronic venous Leg ulcer in United Kingdom
  • 20 Mar 2007 Phase-II clinical trials in Diabetic foot ulcer in United Kingdom (Topical)
  • 20 Mar 2007 Preclinical trials in Acne in United Kingdom (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top